Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014)

Loi, S; Giobbie-Hurder, A; Gombos, A; Bachelot, T; Hui, R; Curigliano, Giuseppe; Campone, M; Biganzoli, L; Bonnefoi, H; JERUSALEM, Guy; Bartsch, R; Rabaglio-Poretti, M; Kammler, R; Maibach, R; Smyth, MJ; Di Leo, A; Colleoni, Marco; Viale, G; Regan, MM; André, F

Unpublished conference/Abstract (Scientific congresses and symposiums)

Loi, S; Giobbie-Hurder, A; Gombos, A et al.

2017 • SABCS

Permalink
https://hdl.handle.net/2268/221416

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

SABCS 2017 - Phase Ib-II study evaluating safety and efficacy of Pembrolizumab ... dias.pdf

Publisher postprint (1.2 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology; Pembrolizumab; Trastuzumab; breast cancer

Disciplines :

Oncology

Author, co-author :

Loi, S

Giobbie-Hurder, A

Gombos, A

Bachelot, T

Hui, R

Curigliano, Giuseppe

Campone, M

Biganzoli, L

Bonnefoi, H

JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Service d'oncologie médicale

More authors (10 more)

Language :

English

Title :

Publication date :

December 2017

Event name :

SABCS

Event place :

San Antonio, United States

Event date :

December 5-9, 2017

By request :

Yes

Audience :

International

Available on ORBi :

since 20 March 2018

Statistics

Number of views

313 (3 by ULiège)

Number of downloads

4 (3 by ULiège)

More statistics